Log In
BCIQ
Print this Print this
 

Portrazza, necitumumab (IMC-11F8, LY3012211)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionHuman IgG1 mAb against EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today